[HTML][HTML] Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international …
G Young, S Becker, C Düring, F Friedrichs… - Journal of Thrombosis …, 2009 - Elsevier
Objective: To determine the relative importance of the factor (F) II G20210A or FV G1691A
mutations as risk factors or predictors for fatal/non-fatal recurrent venous thromboembolism …
mutations as risk factors or predictors for fatal/non-fatal recurrent venous thromboembolism …
[HTML][HTML] Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease
E Mandala, C Lafaras, C Tsioni, M Speletas… - Hippokratia, 2012 - ncbi.nlm.nih.gov
Background: Thromboembolic disease (TED) represents one of the main reasons of
morbitity and mortality in Western World. Venous and arterial thrombotic disorders have long …
morbitity and mortality in Western World. Venous and arterial thrombotic disorders have long …
Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolism
V Limperger, A Torge, B Kiesau, F Langer… - Blood Cells, Molecules …, 2022 - Elsevier
Background To develop and validate a predictive model to determinate patients at increased
risk to suffer from recurrence following a first provoked deep vein thrombosis (VTE) …
risk to suffer from recurrence following a first provoked deep vein thrombosis (VTE) …
Inherited Thrombophilia: Past, Present, and Future Research
JS Koenderman, PH Reitsma - Thrombophilia, 2011 - books.google.com
Thrombophilia is defined as a disorder of hemostasis in which there is a tendency for the
occurrence of thrombosis in veins or arteries due to abnormalities in blood composition …
occurrence of thrombosis in veins or arteries due to abnormalities in blood composition …
Once and only once
FR Rosendaal - Circulation, 2010 - Am Heart Assoc
Venous thrombosis is a fairly common disorder that manifests mainly as deep vein
thrombosis of the leg or pulmonary embolism. It affects 1 in 1000 individuals annually and …
thrombosis of the leg or pulmonary embolism. It affects 1 in 1000 individuals annually and …
[PDF][PDF] An integrative approach to the patient with thrombophilia
G Mitić - Journal of Medical Biochemistry, 2014 - dmbj.org.rs
Venous thromboembolism (VTE) is a multifactorial disease that results from a conjunction of
several risk factors, both inherited and acquired. The younger the person, the more risk …
several risk factors, both inherited and acquired. The younger the person, the more risk …
[HTML][HTML] Direct oral anticoagulants in antithrombin deficiency: initial experience in a single center
BS Bhoelan, R Mulder, MV Lukens… - Thrombosis and …, 2021 - thieme-connect.com
Recently, a paper on the treatment of venous thromboembolism (VTE) in patients with
hereditary antithrombin (AT) deficiency was published. 1 One of the issues the authors …
hereditary antithrombin (AT) deficiency was published. 1 One of the issues the authors …
Thrombophilic and systemic risk factors in patients with retinal vein occlusion
C Kuhli-Hattenbach, W Miesbach, I Scharrer… - Der …, 2011 - Springer
Für die Entstehung retinaler Gefäßverschlüsse kommt der Arteriosklerose eine
entscheidende Rolle zu, sodass eine weiterführende kardiovaskuläre Abklärung unter …
entscheidende Rolle zu, sodass eine weiterführende kardiovaskuläre Abklärung unter …
Venous thrombembolism, thrombophilic defects, combined oral contraception and anticoagulation
J Ott, R Promberger, U Kaufmann, JC Huber… - Archives of gynecology …, 2009 - Springer
Background Several genetic polymorphisms increase the risk for venous thrombembolism
(VTE). In particular, combined oral contraceptives (COCs) are known to enhance the risk for …
(VTE). In particular, combined oral contraceptives (COCs) are known to enhance the risk for …